• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GYRUS ACMI, INC SHOCKPULSE LITHOTRIPSY FOOTSWITCH; LITHOTRIPTOR, ULTRASONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GYRUS ACMI, INC SHOCKPULSE LITHOTRIPSY FOOTSWITCH; LITHOTRIPTOR, ULTRASONIC Back to Search Results
Model Number SPL-FS
Medical Device Problem Code Device Remains Activated (1525)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/09/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device is returned but the device evaluation is not yet completed.As such, a definitive root cause of the reported complaint cannot be determined at this time.Supplemental report(s) will be filed as any relevant new information becomes available.
 
Event or Problem Description
As reported by the olympus territory manager for this event, the device remained active all the time.There is no reported harm to any patient.
 
Additional Manufacturer Narrative
Correction to d4 udi.
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and device evaluation.The device was inspected and the complaint was confirmed.The reported failure was due to a faulty electrical connection caused by a manufacturing process error.The current process does not have a routine checkout procedure to prevent product defects escaping the manufacturing floor.Although patient risk is low and the issue is contained to a single lot, a capa was assigned to implement corrections and preventative actions.The event can be detected by following the instructions for use which state: "perform the prescribed inspections prior to first use and regularly thereafter to ensure continued satisfactory performance.Do not use a shockpulse-se system that fails to meet the criteria stated in the labeling or that has been damaged.Otherwise, injury to the patient, personnel and/or an adverse effect on the procedure could result." olympus will continue to monitor field performance for this device.
 
Additional Manufacturer Narrative
Additional information has been received from the customer.This supplemental report is being submitted to provide this information.
 
Event or Problem Description
Addendum apr 4, 2022: event occurred during set up with no patient involvement.This was the first time use of the device.The device was inspected before issue with no anomalies noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHOCKPULSE LITHOTRIPSY FOOTSWITCH
Common Device Name
LITHOTRIPTOR, ULTRASONIC
Manufacturer (Section D)
GYRUS ACMI, INC
136 turnpike road
southborough PA 01772
Manufacturer Contact
brian motter
9600 louisiana avenue north
brooklyn park, MN 55445
4848965250
MDR Report Key13998832
Report Number3011050570-2022-00035
Device Sequence Number11985706
Product Code FEO
UDI-Device Identifier00821925043695
UDI-Public00821925043695
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K142428
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 06/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSPL-FS
Device Lot NumberFR189625
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/25/2022
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/09/2022
Supplement Date Received by Manufacturer04/04/2022
05/10/2022
06/08/2022
Initial Report FDA Received Date04/04/2022
Supplement Report FDA Received Date04/08/2022
06/06/2022
06/08/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/20/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SPL-GSPL-T
Patient SexUnknown
-
-